IT1249650B - N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico - Google Patents

N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico

Info

Publication number
IT1249650B
IT1249650B ITMI911470A ITMI911470A IT1249650B IT 1249650 B IT1249650 B IT 1249650B IT MI911470 A ITMI911470 A IT MI911470A IT MI911470 A ITMI911470 A IT MI911470A IT 1249650 B IT1249650 B IT 1249650B
Authority
IT
Italy
Prior art keywords
derivatives
cistein
prolil
tioxo
preparation
Prior art date
Application number
ITMI911470A
Other languages
English (en)
Inventor
Stefano Poli
Germano Coppi
Giovanni Signorelli
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to ITMI911470A priority Critical patent/IT1249650B/it
Publication of ITMI911470A0 publication Critical patent/ITMI911470A0/it
Priority to US07/879,907 priority patent/US5254579A/en
Priority to ES92108659T priority patent/ES2052484T1/es
Priority to EP19920108659 priority patent/EP0515995A3/en
Priority to DE199292108659T priority patent/DE515995T1/de
Publication of ITMI911470A1 publication Critical patent/ITMI911470A1/it
Priority to GR930300007T priority patent/GR930300007T1/el
Application granted granted Critical
Publication of IT1249650B publication Critical patent/IT1249650B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Vengono descritti composti ammidici della 5-oxo-L-prolina e della 5-tioxo-L-prolina con L-cisteina e derivati dotati di interessante attività mucolitico-espettorante, antiossidante (radical-scavenger), antielastasica, antienfisema, immunostimolante, epatoprotettiva e di bassa tossicità.Vengono inoltre riportati i procedimenti di sintesi e le forme farmaceutiche per l'impiego in terapia.
ITMI911470A 1991-05-29 1991-05-29 N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico IT1249650B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI911470A IT1249650B (it) 1991-05-29 1991-05-29 N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
US07/879,907 US5254579A (en) 1991-05-29 1992-05-08 N-(5-thioxo-L-prolyl)-L-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
ES92108659T ES2052484T1 (es) 1991-05-29 1992-05-22 N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
EP19920108659 EP0515995A3 (en) 1991-05-29 1992-05-22 N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
DE199292108659T DE515995T1 (de) 1991-05-29 1992-05-22 N-(5-thioxo-l-propyl)-l-cystein und derivate, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
GR930300007T GR930300007T1 (it) 1991-05-29 1993-04-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911470A IT1249650B (it) 1991-05-29 1991-05-29 N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico

Publications (3)

Publication Number Publication Date
ITMI911470A0 ITMI911470A0 (it) 1991-05-29
ITMI911470A1 ITMI911470A1 (it) 1992-11-29
IT1249650B true IT1249650B (it) 1995-03-09

Family

ID=11360007

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911470A IT1249650B (it) 1991-05-29 1991-05-29 N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico

Country Status (6)

Country Link
US (1) US5254579A (it)
EP (1) EP0515995A3 (it)
DE (1) DE515995T1 (it)
ES (1) ES2052484T1 (it)
GR (1) GR930300007T1 (it)
IT (1) IT1249650B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Pharmaceutical compositions comprising cystine derivatives
IT1256178B (it) * 1992-11-30 1995-11-29 Lorenzo Ferrari Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
SE9500897D0 (sv) * 1995-03-14 1995-03-14 Astra Ab The pharmacological use of certain cystine derivatives
US6051584A (en) * 1995-11-13 2000-04-18 Smithkline Beecham Corporation Hemoregulatory compounds
EP0866698A4 (en) * 1995-11-13 1999-03-03 Smithkline Beecham Corp HEMOREGULATORY CONNECTIONS
SE9901573D0 (sv) 1999-05-03 1999-05-03 Astra Ab New compounds
AR023819A1 (es) 1999-05-03 2002-09-04 Astrazeneca Ab FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION
IL157364A0 (en) 2001-02-16 2004-02-19 Daiichi Suntory Pharma Co Ltd Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1
US6644012B2 (en) 2001-11-02 2003-11-11 Alston (Switzerland) Ltd Gas turbine set
US6640550B2 (en) 2001-11-02 2003-11-04 Alstom (Switzerland) Ltd Gas turbo-group with cooling air system
US6523346B1 (en) 2001-11-02 2003-02-25 Alstom (Switzerland) Ltd Process for controlling the cooling air mass flow of a gas turbine set

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8500847A (nl) * 1984-03-29 1985-10-16 Sandoz Ag Gesubstitueerde alfa-aminozuren, hun bereiding en farmaceutische preparaten die ze bevatten.
IT1216096B (it) * 1988-03-15 1990-02-22 Farmaceutica Italiana S P A S L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.

Also Published As

Publication number Publication date
US5254579A (en) 1993-10-19
GR930300007T1 (it) 1993-04-28
ITMI911470A1 (it) 1992-11-29
EP0515995A2 (en) 1992-12-02
ITMI911470A0 (it) 1991-05-29
ES2052484T1 (es) 1994-07-16
DE515995T1 (de) 1993-04-08
EP0515995A3 (en) 1993-07-21

Similar Documents

Publication Publication Date Title
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
IT1244548B (it) Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
ATE188219T1 (de) Pharmazeutische dipeptid zusammensetzungen und verwendungsmethoden.
CY1109869T1 (el) Παραγωγη πεπτιδιων και φαρμακευτικα αποδεκτων αλατων τους, τροποι συνθεσης, χρησης και φαρμακευτικης συνθεσης
ES2058796T3 (es) Aislamiento y elucidacion estructural del depsipeptido citostatico lineal dolastatina 15.
GEP20063799B (en) Tropane derivatives useful in therapy
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
BG101118A (en) Therapeutical compounds
DK0585155T3 (da) Trifluormethylketon-peptidderivater med HLE-inhiberende aktivitet, deres fremstilling og farmaceutiske præparater
DE69206876D1 (de) Nukleosidanalogen enthaltende Antiviren-Zubereitungen
FI891361A0 (fi) Menetelmä farmaseuttisesti vaikuttavien aryylihydratsonien valmistamiseksi
DK0726899T3 (da) Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
IT1249650B (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
GEP20002332B (en) Cefalosporin Derivatives
DE69130063D1 (de) Antivirales arzneimittel enthaltend prostratin
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
KR930017885A (ko) 항종양 조성물 및 종양의 치료방법
RU95110110A (ru) Производные бензофурана, способ их получения, фармкомпозиция и способ лечения
IT1229491B (it) Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
IL93594A0 (en) Pharmaceutical compositions containing an imidazopyrimidone derivative
MX9303985A (es) Nucleosidos terapeuticos.
NO911798D0 (no) 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling.
MX9304466A (es) Derivados de arginina.
ES2067842T3 (es) Uso del factor de necrosis tumoral.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970529